- Home
- FERG vs TAK Comparison
FERG vs TAK Comparison
Compare FERG & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FERG
- TAK
- Stock Information
- Founded
- FERG 1887
- TAK 1781
- Country
- FERG United States
- TAK Japan
- Employees
- FERG N/A
- TAK N/A
- Industry
- FERG Miscellaneous
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- FERG Miscellaneous
- TAK Health Care
- Exchange
- FERG Nasdaq
- TAK Nasdaq
- Market Cap
- FERG 44.8B
- TAK 47.9B
- IPO Year
- FERG N/A
- TAK N/A
- Fundamental
- Price
- FERG $233.58
- TAK $15.52
- Analyst Decision
- FERG Buy
- TAK
- Analyst Count
- FERG 14
- TAK 0
- Target Price
- FERG $221.85
- TAK N/A
- AVG Volume (30 Days)
- FERG 1.1M
- TAK 5.1M
- Earning Date
- FERG 09-16-2025
- TAK 07-30-2025
- Dividend Yield
- FERG 1.42%
- TAK 3.50%
- EPS Growth
- FERG N/A
- TAK N/A
- EPS
- FERG 8.01
- TAK 0.59
- Revenue
- FERG $30,211,000,000.00
- TAK $31,053,301,865.00
- Revenue This Year
- FERG $5.74
- TAK $0.47
- Revenue Next Year
- FERG $5.52
- TAK $0.80
- P/E Ratio
- FERG $29.24
- TAK $26.24
- Revenue Growth
- FERG 2.32
- TAK 1.52
- 52 Week Low
- FERG $146.00
- TAK $12.80
- 52 Week High
- FERG $237.72
- TAK $15.56
- Technical
- Relative Strength Index (RSI)
- FERG 63.82
- TAK 67.50
- Support Level
- FERG $228.21
- TAK $15.27
- Resistance Level
- FERG $235.12
- TAK $15.56
- Average True Range (ATR)
- FERG 3.67
- TAK 0.12
- MACD
- FERG 0.21
- TAK 0.14
- Stochastic Oscillator
- FERG 75.99
- TAK 96.72
About FERG Ferguson plc
Ferguson distributes plumbing and HVAC products to North American repair, maintenance and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 36,000 suppliers. Ferguson engages customers through approximately 1,800 North American branches, over the phone, online, and in residential showrooms. According to Modern Distribution Management, Ferguson is the largest plumbing distributor and second-largest HVAC distributor (next to Watsco) in North America. The firm sold its UK business in 2021 and is now solely focused on the North American market.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.